This Retraction follows an Expression of Concern relating to this article previously published by Portland Press. This article is being retracted from Bioscience Reports at the request of the authors following receipt of a notification from a reader, alerting the Editorial Office to two regions of the figure 6b MI/R + Dex + EX527 panel that also appear in another paper by different authors (“Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway” (Feng et al 2017) doi: 10.18632/oncotarget.14328). The Editorial Office also has concerns regarding the western blot images. The authors wish to retract the article, and the Editor-in-Chief and Editorial Board agree with the retraction.
. 2022 Sep 14;42(9):BSR-2019-4030_RET. doi: 10.1042/BSR-2019-4030_RET
Retraction: Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis
Collection date 2022 Sep 30.
Keywords: Dexmedetomidine, EX527, mTOR, Myocardial ischemia/reperfusion, SIRT1
© 2022 The Author(s).
This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
PMCID: PMC9484009 PMID: 36102153
This retracts the article "Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis" in volume 40, BSR20194030.